Table 5. Predictors of Resident-Industry Relationships.
| Characteristics | Exposure ≥1.5 per month | ||||
| Percentage (%) | Bivariate analysis | Multivariate analysis Final Model* (n = 543) | |||
| OR [CI 95%] | p-value | OR [CI 95%] | p-value | ||
| Gender (n = 543) | |||||
| Male (n = 172) | 55.23 | 1 | 0.352 | ||
| Female (n = 371) | 50.94 | 0.84 [0.58–1.21] | |||
| University (n = 551) | |||||
| Marseille (n = 115) | 51.30 | 1 | 0.031 | ||
| Bordeaux (n = 85) | 56.47 | 1.23 [0.70–2.16] | |||
| Toulouse (n = 132) | 44.70 | 0.77 [0.46–1.27] | |||
| Montpellier (n = 108) | 54.63 | 1.14 [0.67–1.93] | |||
| Nice (n = 20) | 90.00 | 8.54 [1.89–38.51] | |||
| Grenoble (n = 91) | 48.35 | 0.89 [0.51–1.54] | |||
| Specialty (n = 551) | |||||
| Family practice (n = 260) | 50.77 | 1 | <0.001 | 1 | <0.001 |
| Medical specialty† (n = 109) | 66.97 | 1.97 [1.23–3.14] | 1.69 [0.99–2.86] | ||
| Surgery (n = 56) | 64.29 | 1.75 [0.96–3.18] | 1.86 [0.96–3.58] | ||
| Anesthesiology (n = 24) | 12.50 | 0.14 [0.04–0.48] | 0.17 [0.05–0.61] | ||
| Psychiatry (n = 42) | 35.71 | 0.54 [0.27–1.06] | 0.59 [0.29–1.21] | ||
| Others‡ (n = 60) | 46.67 | 0.85 [0.48–1.49] | 0.87 [0.48–1.58] | ||
| Lectures about conflicts of interest during student medical courses (n = 551) | |||||
| No (n = 392) | 53.32 | 1 | 0.364 | ||
| Yes (n = 159) | 49.06 | 0.84 [0.58–1.22] | |||
| Interested in pursuing an academic career (n = 546) | |||||
| No (n = 280) | 51.43 | 1 | 0.721 | ||
| Yes (n = 266) | 53.01 | 1.06 [0.76–1.49] | |||
| Opinion about pharmaceutical industry (n = 551) | |||||
| Negative-neutral (n = 502) | 50.20 | 1 | 0.006 | 1 | 0.032 |
| Positive (n = 49) | 71.43 | 2.48 [1.30–4.72] | 2.12 [1.07–4.22] | ||
| Subscription independent medical journal (n = 548) | |||||
| No (n = 356) | 51.97 | 1 | 0.886 | ||
| Yes (n = 192) | 52.60 | 1.03 [0.72–1.46] | |||
| Change in my practice about drug information (n = 544) | |||||
| No (n = 448) | 51.79 | 1 | 0.542 | ||
| Yes (n = 96) | 55.21 | 1.15 [0.74–1.79] | |||
| Number of years in residence (n = 551) | |||||
| 0 year (n = 114) | 76.32 | 1 | <0.001 | 1 | <0.001 |
| 1 years (n = 134) | 52.99 | 0.35 [0.20–0.61] | 0.38 [0.21–0.67] | ||
| 2 years (n = 175) | 37.71 | 0.19 [0.11–0.32] | 0.20 [0.11–0.34] | ||
| ≥3 years (n = 128) | 49.22 | 0.30 [0.17–0.52] | 0.25 [0.14–0.46] | ||
†
Medical specialty: Cardiology, Neurology, Gastroenterology, Internal Medicine, Dermatology, Radiology, Nephrology, Pulmonology, Oncology, Hematology, Endocrinology, Physical Medicine and Rehabilitation, Rheumatology, Genetic.
‡
Others: Pediatry, Gynecology, Obstetric, Public health, Biology.
* The following factors were therefore included in the model: gender, universities, medical specialties, education or any awarenessraising action about conflicts of interest, opinion about pharmaceutical industry, number of years in residence, change in their practice about drug information since Mediator's affair.
Abbreviations OR: Odds Ratio; CI 95%: Confidence Interval 95%.